Intrinsic Value of S&P & Nasdaq Contact Us

eFFECTOR Therapeutics, Inc. EFTR OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.50
+2749900%

Stock Statistics — EFTR

eFFECTOR Therapeutics, Inc. (EFTR) has a market capitalization of $941.00 and trades at $0.00. The 52-week range is 0.0002-0.01.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-16.37.

The stock has a beta of 0.89, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0002-0.01
Volume331
Avg Volume (30D)272
Market Cap$941.00
Beta (1Y)0.89
Company
IPO Date2021-03-01
Employees14
CEODavide Ruggero
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS28202V2079
CUSIP28202V108
Income (Latest Year)
Gross Profit$-22.92M
EBITDA$-33.73M
Operating Income$-33.84M
Net Income$-35.81M
EPS$-16.37
EPS Diluted$-16.37
Shares Outstanding$2.19M
Balance Sheet (Latest Year)
Total Assets$20.54M
Current Assets$19.84M
Cash & ST Investments$18.37M
Total Liabilities$26.34M
Total Debt$20.55M
Net Debt$5.67M
Total Equity$-5.8M
Debt / Equity-3.55
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message